FDA wants more from J&J
Chronic pain patients have to wait even longer for access to twice-daily tapentadol.
Chronic pain patients have to wait even longer for access to twice-daily tapentadol.
It's certainly interesting to consider Latin American countries from a US perspective. Aside from the friendlier time differences, transportation and logistics could be simpler, as the article suggests. From a…
Today we hear the news that Covance has done it again. Today they acquired two European R&D sites from Sanofi for $25 million. In addition, Sanofi agreed to purchase R&D…
Welcome to my new blog and web site! Lacerta Bio has been organized to provide a range of pharmaceutical and biotechnology business development services. Please visit our About page to…